Tevogen (TVGN) Payables (2021 - 2026)

Tevogen (TVGN) has reported Payables for 6 consecutive years, with $5.4 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Payables fell 13.71% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (down 13.71% YoY), and the FY2025 full-year result was $5.0 million, down 27.15% from the prior year.
• Payables grew to $5.4 million in Q1 2026 per TVGN's latest filing, from $5.0 million in the prior quarter.
• Across five years, Payables topped out at $84.1 million in Q4 2023 and bottomed at $128999.0 in Q1 2022.
• Historically, Payables has averaged $8.6 million across 5 years, with a median of $5.0 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Payables surged 39875.66% in 2023, then tumbled 91.86% in 2024.
• Over 5 years, Payables stood at $210454.0 in 2022, then soared by 39875.66% to $84.1 million in 2023, then sank by 91.86% to $6.9 million in 2024, then decreased by 27.15% to $5.0 million in 2025, then grew by 9.19% to $5.4 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $5.4 million, $5.0 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.